Publications by authors named "Karin Travers"

Claim this Profile
B
Budget impact analysis of niraparib for first-line maintenance therapy in advanced ovarian cancer from a US payer perspective.
Jinan Liu, Carol Hawkes, Lydia Walder, Chloe Spalding, Karin Travers

J Manag Care Spec Pharm· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Niraparib Maintenance Treatment Improves Time Without Symptoms or Toxicity (TWiST) Versus Routine Surveillance in Recurrent Ovarian Cancer: A TWiST Analysis of the ENGOT-OV16/NOVA Trial.
Ursula A Matulonis, Lydia Walder, Trine J Nøttrup, Paul Bessette, Sven Mahner, Karin Travers

J Clin Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world adverse events with niraparib 200 mg/day maintenance therapy in ovarian cancer: a retrospective study.
Jack R Gallagher, Kylee Jean Heap, Susan Carroll, Karin Travers, Brooke Harrow

Future Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budget impact of niraparib as maintenance treatment in recurrent ovarian cancer following platinum-based chemotherapy.
Kurt Neeser, William M O'Neil, Lee Stern, Brooke Harrow, Karin Travers

J Comp Eff Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effectiveness and Value of Palliative Care in the Outpatient Setting.
Courtney Cunningham, Daniel Ollendorf, Karin Travers

JAMA Intern Med· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic literature review and network meta-analysis of treatments for patients with untreated multiple myeloma not eligible for stem cell transplantation.
Katja Weisel, Chantal Doyen, Meletios Dimopoulos, Adrian Yee, Juan José Lahuerta, Karin Travers

Leuk Lymphoma· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and temporal trends in patient registries: focus on the life sciences industry, 1981-2012.
Karin Travers, Rachel H Sallum, Meghan D Burns, Charles E Barr, Mary S Beattie

Pharmacoepidemiol Drug Saf· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The humanistic burden of head and neck cancer: a systematic literature review.
Erika Wissinger, Ingolf Griebsch, Juliane Lungershausen, Michael Byrnes, Karin Travers

Pharmacoeconomics· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Major depressive disorder in Africa and the Middle East: a systematic literature review.
Karin U Travers, Tiffany D Pokora, Sarah M Cadarette, Joaquin F Mould

Expert Rev Pharmacoecon Outcomes Res· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden and management of chronic kidney disease in Japan: systematic review of the literature.
Karin Travers, Amber Martin, Zarmina Khankhel, Kristina S Boye, Lauren J Lee

Int J Nephrol Renovasc Dis· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humanistic and economic burden of generalized anxiety disorder in North America and Europe.
Dennis A Revicki, Karin Travers, Kathleen W Wyrwich, Henrik Svedsäter, Julie Locklear

J Affect Disord· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs.
John M Stelling, Karin Travers, Ronald N Jones, Philip J Turner, Thomas F O'Brien

Emerg Infect Dis· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excess infections due to antimicrobial resistance: the "Attributable Fraction".
Michael Barza, Karin Travers

Clin Infect Dis· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morbidity of infections caused by antimicrobial-resistant bacteria.
Karin Travers, Michael Barza

Clin Infect Dis· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of assessments of the human health risk associated with the use of antimicrobial agents in agriculture.
John C Bailar, Karin Travers

Clin Infect Dis· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis